EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Azithromycin for Bacterial Watery Diarrhea: A Reanalysis of the AntiBiotics for Children With Severe Diarrhea (ABCD) Trial Incorporating Molecular Diagnostics

Patricia B Pavlinac iD, James A Platts-Mills, Jie Liu, Hannah E Atlas, Jean Gratz, Darwin Operario, Elizabeth T Rogawski McQuade, Dilruba Ahmed, Tahmeed Ahmed iD, Tahmina Alam, Per Ashorn, Henry Badji und 38 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad252 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Patricia B Pavlinac und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health. Hauptthemen laut MEDLINE: Bacterial Infections, Cryptosporidiosis, Cryptosporidium, Dysentery. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: World Health Organization, NIAID NIH HHS, Gates Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Bacterial pathogens cause substantial diarrhea morbidity and mortality among children living in endemic settings, yet antimicrobial treatment is only recommended for dysentery or suspected cholera.

Methods

AntiBiotics for Children with severe Diarrhea was a 7-country, placebo-controlled, double-blind efficacy trial of azithromycin in children 2–23 months of age with watery diarrhea accompanied by dehydration or malnutrition. We tested fecal samples for enteric pathogens utilizing quantitative polymerase chain reaction to identify likely and possible bacterial etiologies and employed pathogen-specific cutoffs based on genomic target quantity in previous case-control diarrhea etiology studies to identify likely and possible bacterial etiologies.

Results

Among 6692 children, the leading likely etiologies were rotavirus (21.1%), enterotoxigenic Escherichia coli encoding heat-stable toxin (13.3%), Shigella (12.6%), and Cryptosporidium (9.6%). More than one-quarter (1894 [28.3%]) had a likely and 1153 (17.3%) a possible bacterial etiology. Day 3 diarrhea was less common in those randomized to azithromycin versus placebo among children with a likely bacterial etiology (risk difference [RD]likely, −11.6 [95% confidence interval {CI}, −15.6 to −7.6]) and possible bacterial etiology (RDpossible, −8.7 [95% CI, −13.0 to −4.4]) but not in other children (RDunlikely, −0.3% [95% CI, −2.9% to 2.3%]). A similar association was observed for 90-day hospitalization or death (RDlikely, −3.1 [95% CI, −5.3 to −1.0]; RDpossible, −2.3 [95% CI, −4.5 to −.01]; RDunlikely, −0.6 [95% CI, −1.9 to .6]). The magnitude of risk differences was similar among specific likely bacterial etiologies, including Shigella.

Conclusions

Acute watery diarrhea confirmed or presumed to be of bacterial etiology may benefit from azithromycin treatment. Clinical Trials Registration NCT03130114.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial InfectionsCryptosporidiosisCryptosporidiumDysenteryShigellaHumansInfantAnti-Bacterial AgentsAzithromycinBacteriaDiarrheaPathology, Molecular

Stichwörter der Autor:innen

Shigellaazithromycinbacterial diarrheamolecular diagnosticspediatric diarrhea

Substanzen

Anti-Bacterial AgentsAzithromycin

Autor:innen und Institutionen

  • Department of Global Health.
  • Department of Epidemiology, University of Washington, Seattle, WA, USA.
  • Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, Virginia, USA.
  • School of Public Health, Qingdao University, Qingdao, China.
  • Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA.
  • Laboratory Sciences and Services Division.

ORCID-Profile: Patricia B Pavlinac, Tahmeed Ahmed, Christopher P Duggan

Förderung

  • World Health Organization
  • NIAID NIH HHS
  • Gates Foundation
  • Bill & Melinda Gates Foundation

Zitieren

APA

Pavlinac, P. B., Platts-Mills, J. A., Liu, J., Atlas, H. E., Gratz, J., Operario, D., Rogawski McQuade, E. T., Ahmed, D., Ahmed, T., Alam, T., Ashorn, P., Badji, H., Bahl, R., Bar-Zeev, N., Chisti, M. J., Cornick, J., Chauhan, A., De Costa, A., Deb, S., …, & AntiBiotics for Children with severe Diarrhea (ABCD) Study Group (2024). Azithromycin for Bacterial Watery Diarrhea: A Reanalysis of the AntiBiotics for Children With Severe Diarrhea (ABCD) Trial Incorporating Molecular Diagnostics. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad252

Vancouver

Pavlinac PB, Platts-Mills JA, Liu J, Atlas HE, Gratz J, Operario D, et al. Azithromycin for Bacterial Watery Diarrhea: A Reanalysis of the AntiBiotics for Children With Severe Diarrhea (ABCD) Trial Incorporating Molecular Diagnostics. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad252

BibTeX
@article{Pavlinac2024,
  author = {Pavlinac, Patricia B and Platts-Mills, James A and Liu, Jie and Atlas, Hannah E and Gratz, Jean and Operario, Darwin and Rogawski McQuade, Elizabeth T and Ahmed, Dilruba and Ahmed, Tahmeed and Alam, Tahmina and Ashorn, Per and Badji, Henry and Bahl, Rajiv and Bar-Zeev, Naor and Chisti, Mohammod Jobayer and Cornick, Jen and Chauhan, Aishwarya and De Costa, Ayesha and Deb, Saikat and Dhingra, Usha and Dube, Queen and Duggan, Christopher P and Freyne, Bridget and Gumbi, Wilson and Hotwani, Aneeta and Kabir, Mamun and Islam, Ohedul and Kabir, Furqan and Kasumba, Irene and Kibwana, Upendo and Kotloff, Karen L and Khan, Shaila S and Maiden, Victor and Manji, Karim and Mehta, Ashka and Ndeketa, Latif and Praharaj, Ira and Qamar, Farah Naz and Sazawal, Sunil and Simon, Jonathon and Singa, Benson O and Somji, Sarah and Sow, Samba O and Tapia, Milagritos D and Tigoi, Caroline and Toure, Aliou and Walson, Judd L and Yousafzai, Mohammad Tahir and Houpt, Eric R and AntiBiotics for Children with severe Diarrhea (ABCD) Study Group, AntiBiotics for Children with severe Diarrhea (ABCD) Study Group},
  title = {Azithromycin for Bacterial Watery Diarrhea: A Reanalysis of the AntiBiotics for Children With Severe Diarrhea (ABCD) Trial Incorporating Molecular Diagnostics},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad252}
}
Kostenlos starten →